Knockdown of SHP-1 Enhances Endothelial Cell Retention for Vascular Regeneration Available to Purchase

Atherosclerosis is the leading cause of morbidity and mortality in the developed world. A common treatment option is arterial bypass surgery, which requires the use of a vascular graft. Autologous vein is the current gold standard for use as a vascular graft; however, donor site morbidity and inconsistent availability have provided an impetus to explore alternative graft sources.